Delivery Order SPE2DB22D2206-SPE2DB25FFA38

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,909.94 delivery order contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a November 2024 completion date. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is valued at $1,544.40 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of RYTARY ER 36.25 MG-145 MG capsules. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,922.44 firm fixed-price delivery order is for the pharmaceutical product RYTARY ER 48.75 MG-195 MG CAP 100S, with a performance period through November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,330.91 firm fixed-price delivery order contract is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,944.31, is for the provision of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,238.29 firm fixed-price delivery order is for 4566661715 RYTARY ER 48.75 MG-195 MG CAP 100S, a specialty medication. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,661.65, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules in quantities of 100. The contract has a completion date of June 6, 2024 and is structured as a firm fixed price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen holds a substantial...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,734.70, is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,865.61 firm fixed-price delivery order is for the supply of RYTARY ER 61.25 MG-245 MG capsules. The contract has an ultimate completion date of October 17, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,957.88 firm fixed-price delivery order is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, with a performance period through March 16, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFA38
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.66, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The award covers the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, to support military healthcare programs globally. As an open competition contract with no set-aside designation, Amerisourcebergen's extensive experience and capabilities in providing a comprehensive range of pharmaceutical products and medical supplies to federal agencies, including the military and veterans' healthcare systems, make it a key vendor for the DLA. This contract award is part of Amerisourcebergen's broader portfolio of federal contract vehicles, including a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000.

Generated 4/9/25, 9:54 AM